Olverembatinib, a multikinase inhibitor that modulates lipid metabolism, in advanced succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 1b study and translational researchRui‐Hua Xu, Zhiyan Liang, Jing Yang et al.|Signal Transduction and Targeted Therapy|2025Cited by 4